| Name | Title | Contact Details |
|---|
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
Preferred Health Strategies is a Rye, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2019, Zing Health Holdings Inc. is a groundbreaking tech-enabled insurance company making Medicare Advantage the best it can be for those 65 and over or with long-term disability. Zing Health`s community-based approach addresses social determinants of health to keep individuals and communities healthy and returns the physician and the member to the center of the healthcare equation. This gives each member personalized care and service tailored to their singular needs. Members also receive individualized assistance to make their transition to Zing Health as easy as possible, and have the ability to personalize their plans, access to facilities designed to help them better meet their healthcare needs, and a dedicated care team.
MedCare and its affiliated entities manage approximately $1 billion in assets, the substantial majority of which are related to the medical and healthcare services industry.
Strand Life Sciences was founded in 2000 by four computer scientists with one objective: to apply the algorithms of computer coding to the life sciences. We leveraged this unique convergence of technology and biology expertise to develop a strong portfolio of products internationally that support research and diagnosis and treatment of disease. Today, our products are used in more than 2,000 scientific laboratories and 100 hospitals around the world.